CyberKnife radiosurgery for prostate cancer

Recently, new data have emerged that show promising outcomes with minimal toxicity for CyberKnife SBRT of prostate cancer.

Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer

Overall, these results may have implications for patient and physician clinical decision making which are often influenced by QOL. These differences in sexual, urinary and bowel QOL should be losely considered in selecting the right treatment, especially in evaluating the value of non-invasive treatments, such as SBRT.

SBRT for Non-Small Cell Carcinoma

Using the TomoTherapy® Hi·Art® system’s precise dose guidance capabilities, the oncologist delivered intense radiation directly to the tumor during a week and a half of treatment. The patient experienced no side effects during this time and continued to work as a nurse. Three years later, she remains disease free.

Non-Invasive Stereotactic Radiosurgical Treatment of Non-Small Cell Lung Cancer

This patient had an excellent initial outcome with the CyberKnife System using Xsight® Lung Tracking; the patient was able to undergo treatment completely non-invasively without implanted fiducials or markers.

Synchronous Bilateral Stage 1A Non-Small Cell Carcinoma

Patient was unwilling to undergo a second thoracotomy, and instead chose to receive CyberKnife® treatment of the lesion with concurrent chemotherapy.

Non-Small Cell Lung Cancer - Left Upper Lung

Three months after treatment, the patient reported no evidence of local regional recurrence or treatment-related toxicity.

Prostate Advances in Comparative Evidence (PACE)

This study is an international multicenter randomized study of organ confined low and intermediate risk prostate cancer and is composed of two parallel randomization schemes based on applicability of surgery as a treatment for the patient. Patients for whom surgery is a consideration are randomized to either laparoscopic or da Vinci prostatectomy or CyberKnife prostate SBRT(also known as CyberKnife radiosurgery). Patients for whom surgery is not a consideration are randomized to either conventionally fractionated radiation therapy or CyberKnife prostate SBRT. Efficacy, toxicity and quality of life outcomes will be compared across the pairs in each randomization.